经营模式:贸易商,生产商,员工人数:5-10注册资金:100万人民币 公司评价 暂时还没有评价我要评价 该公司其他产品 HSP90 protein Antibody价格:￥3300/支产品详情:南京沃博生物科技有限公司是一家专注于生命科学和生物技术领域,致力于为客户提供一系列高质量和有绝对价格竞争力的产品,包括分子... ...
Heat shock protein 90 (HSP90) is an important molecular chaperone in plants. However, HSP90-mediated plant immune response remains elusive in cassava. In this study, cassava bacterial blight (CBB) induces the expression of MeHsf8, which directly targets MeHSP90.9 to activate its expression and...
热休克蛋白Heat Shock Proteins (HSPs)是在从细菌到哺乳动物中广泛存在一类热应激蛋白质。当有机体暴露于高温的时候,就会由热激发合成此种蛋白,来保护有机体自身。许多热休克蛋白具有分子伴侣活性。 按照蛋白的大小,热休克蛋白共分为五类,分别为HSP110、HSP90、HSP70、HSP60 以及小分子热休克蛋白small Heat Shock Pr...
英文名称:Heat Shock Protein 90 (HSP90) Antibody (HRP),中文名称:热休克蛋白90(HSP90)抗体(HRP),产品货号:Catalogue No: abx443396,HSP90抗体是一种抗HSP90的小鼠单克隆抗体。目标HSP90反应性人、鼠、大鼠、牛、猪、兔、鸡宿主鼠克隆性
Novel 1,5 diphenylpyrazole derivatives of the formula (I), in which R 1 -R 6 have the meanings indicated in Claim 1 , are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 ...
HSP90 | Heat shock protein 90 (AS05063) 产品编号:AS05 063 产品介绍 服务承诺 订货流程 相关产品推荐 Agrisera 品牌说明: Agrisera公司成立于1980年,专注于研发高品质稀有的单克隆及多克隆抗体。Agrisera抗体主要集中在模式植物及其他植物的生理、病理相关的蛋白抗体、涵盖物种全面,包括了模式植物、作物、藻类细菌...
Heat shock protein 90RNA helicase DDX5autophagyβ-catenin pathwayBackground & Aims: Hepatocellular carcinoma (HCC), the main type of liver cancer, has a high morbidity and mortality rate and poor prognosis. RNA helicase Ddoi:10.2139/ssrn.3576753Zhang, Ting...
Heat shock protein 90(HSP90) is a molecular chaperone responsible for the maturation and stabilization of many client proteins [153]. It regulates the homeostasis ofmitochondrial proteins, maintaining mitochondrial function [154,155]. HSP90 also regulates angiogenesis, proliferation, mig...
英文名称:Heat Shock Protein 90 AntibodyHeat Shock Protein 90 Antibody is available 12 times 来自 Mbs polyclonals labs,中文名称:热休克蛋白90抗体热休克蛋白90抗体有效12,产品货号:MBS615877,热休克蛋白90抗体热休克蛋白90抗体
Gastric cancer (GC) remains the fifth most common cancer worldwide. Heat-shock protein 90 (HSP90) has become an attractive therapeutic target in treating cancers, because of its abnormally high expression in cancers. Several successful cases of HSP90 inhibitors capable of inhibiting GC inspired us...